Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Caffeine as a Therapeutic Agent in Parkinson's Disease

NCT01738178 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT01738178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01738178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Caffeine as a Therapeutic Agent in Parkinson's Disease
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2014
Completion date
December 1, 2016
Enrollment
119 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease